Paul Wong
Dr. Paul Wong is a member of NERA's Health Care and Life Sciences Practice, and NERA’s Antitrust and Competition Practice. Since joining NERA, Dr. Wong has consulted on a variety of health care mergers, including the Advocate-NorthShore hospital merger challenged by the Federal Trade Commission, the Aetna-Humana and Centene-Health Net health insurance mergers, as well as mergers involving major hospital systems in more than 20 states. Dr. Wong has also consulted on antitrust litigations in health care industries, including those involving hospitals, multispecialty physician groups, health insurers, medical devices, medical supply distribution, and hospital equipment supply and rental. Of note, Dr. Wong was the lead consultant for USA v. Carolinas Healthcare System, involving “steering provisions” in hospital reimbursement contracts, and State of Washington v. Franciscan Health System, involving the challenge of two consummated acquisitions of physician groups.
Dr. Wong has previous professional experience in health care services research and health care analytics, and he has worked as an investment manager. In addition, Dr. Wong teaches economics at the Anderson Graduate School of Management at the University of California, Riverside (UCR). Dr. Wong has also conducted academic research on a variety of healthcare and antitrust issues, and published articles in journals such as Population Health Management, Loyola University Chicago Law Journal, and Competition. Notably, Dr. Wong has written multiple papers analyzing competition and regulation in the US health insurance industry. As well, Dr. Wong has researched the impact of patient-centered care on patients’ medical costs, and how competition impacts patenting and innovation in agricultural biotechnology. Dr. Wong has presented seminars to numerous organizations, including the US Department of Justice, the American Society of Health Economists, the American Health Lawyers Association, and the American Bar Association.
